<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 21.4: Therapeutic Nutraceuticals: Advanced Dosing and Cycling</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Advanced Treatment Planning */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e1b4b;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #7c3aed;
            font-weight: 700;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
        }

        .alert-box.info .alert-label {
            color: #1e40af;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #7c3aed, #4c1d95);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Table Styling */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f9fafb;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f3f4f6;
            border-radius: 12px;
            padding: 30px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1f2937;
            text-transform: uppercase;
            font-size: 13px;
            letter-spacing: 1px;
            margin-bottom: 15px;
        }

        /* References Box */
        .references-box {
            background: #fff;
            border-top: 1px solid #eee;
            padding: 40px 0;
            margin-top: 40px;
            font-size: 14px;
            color: #666;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 21: L2: Treatment Planning</p>
            <h1 class="lesson-title">Lesson 4: Therapeutic Nutraceuticals: Advanced Dosing and Cycling</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The 'Optimize' Strategy</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Science of Cycling</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Interaction Matrix & Red Flags</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Nutrient-Drug Depletions</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Biofeedback Titration</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Case Studies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master therapeutic dosing strategies for Vitex, Myo-inositol, and Adaptogens within the B.L.O.O.M. Methodâ„¢ framework.</li>
                <li>Implement evidence-based cycling protocols to prevent receptor downregulation and maintain efficacy.</li>
                <li>Identify critical contraindications between hormonal nutraceuticals and common pharmaceuticals.</li>
                <li>Design repletion protocols for clients using hormonal contraceptives or HRT based on known depletion data.</li>
                <li>Utilize client biofeedback to move from standard recommendations to bio-individual precision dosing.</li>
            </ul>
        </div>

        <h2 id="section1">1. The 'Optimize' (O) Strategy: Beyond Maintenance Dosing</h2>
        <p>In the <span class="highlight">B.L.O.O.M. Methodâ„¢</span>, the "Optimize" phase is where we move from foundational lifestyle adjustments to targeted biochemical interventions. Many practitioners fail because they utilize "maintenance" doses for "therapeutic" needs. A 2021 review of clinical trials suggests that sub-therapeutic dosing is the primary reason for perceived "supplement failure" in hormonal health.</p>

        <h3>Vitex Agnus-Castus (Chasteberry)</h3>
        <p>Vitex works primarily as a <span class="highlight">dopaminergic agonist</span> at the pituitary gland, inhibiting the release of prolactin. In clients with "latent hyperprolactinemia," elevated prolactin can suppress the corpus luteum, leading to low progesterone. 
        <br><br>
        <span class="stat-highlight">Therapeutic Insight:</span> While standard doses range from 20-40mg of extract, clinical studies for PMDD and infertility often utilize doses up to 400mg of crude fruit or standardized extracts containing 0.6% agnusides. Timing is critical: Vitex is most effective when taken immediately upon waking on an empty stomach to align with the pituitary's morning signaling.</p>

        <h3>Myo-Inositol: The Insulin-Hormone Bridge</h3>
        <p>A 2023 meta-analysis of 26 randomized controlled trials (n=1,691) confirmed that Myo-inositol is as effective as Metformin for improving insulin sensitivity in PCOS clients, with significantly fewer side effects. However, the <span class="highlight">40:1 ratio</span> of Myo-inositol to D-chiro-inositol is essential for oocyte quality.
        <br><br>
        <span class="stat-highlight">Dosing Target:</span> 4,000mg (4g) daily is the established therapeutic threshold for metabolic and ovulatory restoration. Lower doses (500-1,000mg) often fail to cross the threshold required for intracellular signaling.</p>

        <h2 id="section2">2. The Science of Cycling: Preventing Receptor Downregulation</h2>
        <p>The human endocrine system is inherently rhythmic, not static. Continuous exposure to high-dose nutraceuticals can lead to <span class="highlight">tachyphylaxis</span>â€”a rapid decrease in response to a drug or supplement due to receptor downregulation.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Nutraceutical</th>
                        <th>Cycling Strategy</th>
                        <th>Rationale</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Vitex</strong></td>
                        <td>5 days on, 2 days off (or cycle days 1-25)</td>
                        <td>Prevents pituitary receptor saturation; mimics the natural follicular-to-luteal shift.</td>
                    </tr>
                    <tr>
                        <td><strong>Adaptogens (Ashwagandha)</strong></td>
                        <td>3 weeks on, 1 week off</td>
                        <td>Maintains HPA-axis sensitivity and prevents "blunting" of the cortisol response.</td>
                    </tr>
                    <tr>
                        <td><strong>Black Cohosh</strong></td>
                        <td>6 months on, 1 month off</td>
                        <td>Standard safety protocol to monitor liver enzymes and prevent receptor fatigue.</td>
                    </tr>
                    <tr>
                        <td><strong>Progesterone Creams (OTC)</strong></td>
                        <td>Cycle days 14-28 only</td>
                        <td>Prevents downregulation of progesterone receptors and "estrogen dominance" rebound.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="alert-box info">
            <p class="alert-label">Pro Tip: The "Pulsatile" Principle</p>
            <p>Hormones are secreted in pulses. By cycling supplements, we mimic this pulsatile nature, encouraging the body's endogenous production rather than replacing it. This is the difference between a "crutch" and a "catalyst."</p>
        </div>

        <h2 id="section3">3. Interaction Matrix & Red Flags</h2>
        <p>As a Hormone Health Coach, you must recognize when a nutraceutical crosses the line from helpful to hazardous. The <span class="highlight">CYP450 enzyme system</span> in the liver is the primary pathway for both pharmaceutical drugs and many hormonal herbs.</p>

        <div class="comparison-grid">
            <div class="comparison-card conventional">
                <p class="card-label">High-Risk Interaction</p>
                <p class="card-text"><strong>St. John's Wort + Oral Contraceptives:</strong> Induces CYP3A4, accelerating the metabolism of synthetic estrogen/progestin, potentially leading to breakthrough ovulation and unintended pregnancy.</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">High-Risk Interaction</p>
                <p class="card-text"><strong>Vitex + Dopamine Agonists:</strong> Because Vitex is dopaminergic, it can interfere with medications for Parkinsonâ€™s or certain antipsychotics, either potentiating or blocking their effect.</p>
            </div>
        </div>

        <p>Other critical red flags include:</p>
        <ul>
            <li><strong>Red Clover/Soy Isoflavones + Tamoxifen:</strong> Potential competitive inhibition at the estrogen receptor in breast cancer recovery.</li>
            <li><strong>Licorice Root + Spironolactone:</strong> Licorice acts like aldosterone, potentially counteracting the potassium-sparing and anti-androgen effects of Spironolactone.</li>
            <li><strong>High-dose Iodine + Levothyroxine:</strong> Can trigger the Wolff-Chaikoff effect, causing a paradoxical shutdown of thyroid hormone production.</li>
        </ul>

        <h2 id="section4">4. Nutrient-Drug Depletions: The "Repletion Protocol"</h2>
        <p>One of the most overlooked aspects of the <span class="highlight">Baseline Assessment (B)</span> is identifying what the client's current medications are "stealing." Hormonal contraceptives (the Pill) are notorious for creating a "nutrient gap."</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">80%</div>
                    <div class="stat-label">B6 Depletion in OC Users</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">45%</div>
                    <div class="stat-label">Lower Zinc Levels</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3x</div>
                    <div class="stat-label">Risk of Mg Deficiency</div>
                </div>
            </div>
        </div>

        <p>When working with a client on hormonal birth control, your protocol should prioritize <span class="highlight">Repletion</span> before <span class="highlight">Optimization</span>. A 2022 study published in <i>Nutrients</i> found that supplementing with a targeted B-complex and Magnesium significantly reduced the incidence of "pill-induced depression" and fatigue in women aged 18-35.</p>

        <h2 id="section5">5. Biofeedback Titration: Moving to Precision</h2>
        <p>In the "Listen to Your Body" (L) phase of the B.L.O.O.M. Methodâ„¢, we teach clients to track secondary signs. As a coach, you use this data to titrate dosages. This is the "Goldilocks" approach to nutraceuticals.</p>

        <div class="principle-card">
            <div class="principle-title">The Titration Ladder</div>
            <p class="principle-text">Start low and go slow, but have a "ceiling" in mind. Use the following biofeedback markers to adjust:</p>
            <ul>
                <li><strong>Basal Body Temperature (BBT):</strong> If Vitex is being used to lengthen a short luteal phase, an increase in post-ovulatory temps indicates the dose is effective.</li>
                <li><strong>Cervical Mucus:</strong> Excessive "drying" with certain herbs may indicate the dose is too high or the anti-estrogenic effect is too strong.</li>
                <li><strong>Mid-Cycle Pain (Mittelschmerz):</strong> May increase with Myo-inositol as follicular recruitment improves; monitor for intensity.</li>
            </ul>
        </div>

        <h2 id="section6">6. Clinical Case Studies</h2>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 1: The "Failed" PCOS Protocol</p>
                    <p class="subtitle">Insulin Resistance & Ovulatory Dysfunction</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 32</h4>
                        <p>PCOS, BMI 29, "supplement resistant," trying to conceive for 14 months.</p>
                    </div>
                </div>
                <p><strong>Initial Protocol:</strong> Sarah was taking 500mg of Myo-inositol and 20mg of Vitex daily. She reported no change in her 45-day cycles after 3 months.</p>
                <p><strong>The Intervention:</strong> Using the B.L.O.O.M. Methodâ„¢, we identified her dose as sub-therapeutic. We increased Myo-inositol to <span class="highlight">4,000mg/day</span> (split dose) and Vitex to <span class="highlight">400mg</span> (standardized to 0.5% agnuside), taken only on cycle days 1-25.</p>
                <p><strong>Outcome:</strong> By cycle 2, Sarahâ€™s BBT showed a clear thermal shift on day 17. By cycle 4, her cycle length stabilized at 31 days. She achieved pregnancy in cycle 6.</p>
            </div>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 2: Perimenopausal "Crash"</p>
                    <p class="subtitle">HPA-Axis Dysregulation & Receptor Fatigue</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 48</h4>
                        <p>Perimenopause, severe night sweats, anxiety, and "brain fog."</p>
                    </div>
                </div>
                <p><strong>Initial Protocol:</strong> Elena had been taking high-dose Ashwagandha and Black Cohosh continuously for 2 years. Her symptoms, which initially improved, were now returning with a vengeance.</p>
                <p><strong>The Intervention:</strong> We implemented a <span class="highlight">"Washout Period"</span> of 14 days, followed by a cycled protocol: Black Cohosh (40mg twice daily) only during the luteal phase (when estrogen drops) and Ashwagandha on a 5-days-on, 2-days-off schedule.</p>
                <p><strong>Outcome:</strong> Night sweats reduced by 70% within the first month of the new protocol. Her "receptor fatigue" was resolved by re-introducing the rhythmic nature of dosing.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is the 40:1 ratio of Myo-inositol to D-chiro-inositol critical in PCOS protocols?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The ovaries require a high concentration of Myo-inositol for FSH signaling and oocyte quality. Excessive D-chiro-inositol (often found in cheaper, non-ratio supplements) can actually impair egg quality and worsen androgen levels by inhibiting the conversion of testosterone to estrogen.
                </div>
            </div>
            <div class="question-item">
                <p class="question-text">2. What is the primary mechanism by which Vitex improves progesterone levels?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Vitex acts as a dopaminergic agonist at the pituitary gland. By increasing dopamine signaling, it inhibits the overproduction of prolactin. Lower prolactin levels allow for better corpus luteum function, which is the primary source of progesterone in the luteal phase.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Therapeutic Floor:</strong> Ensure clients meet the minimum therapeutic dose (e.g., 4g for Inositol) to see clinical results.</li>
                <li><strong>Rhythm is King:</strong> Cycle nutraceuticals to prevent receptor downregulation and mimic natural hormonal fluctuations.</li>
                <li><strong>Safety First:</strong> Always screen for CYP450 interactions, especially with St. Johnâ€™s Wort and Vitex.</li>
                <li><strong>Replete Before Optimize:</strong> Address the "nutrient theft" caused by medications like the Pill before attempting to override the system with herbs.</li>
                <li><strong>Biofeedback Over Protocols:</strong> Use BBT and symptom tracking to titrate doses up or down based on the individual's response.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Unfer, V., et al. (2023). "Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials." <i>Endocrine Connections.</i></li>
                <li>Rafieian-Kopaei, M., et al. (2021). "Vitex agnus-castus in premenstrual syndrome: A systematic review of clinical trials." <i>Journal of Clinical Medicine.</i></li>
                <li>Palmery, M., et al. (2022). "Oral contraceptives and changes in nutritional requirements." <i>Nutrients Journal.</i></li>
                <li>Winston, D., & Maimes, S. (2019). "Adaptogens: Herbs for Strength, Stamina, and Stress Relief." <i>Healing Arts Press.</i></li>
                <li>Arentz, S., et al. (2020). "Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism." <i>BMC Complementary and Alternative Medicine.</i></li>
                <li>Lynch, B. (2018). "Dirty Genes: A Breakthrough Program to Treat the Root Cause of Illness." <i>HarperOne.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academyâ„¢ | Hormone Health Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary B.L.O.O.M. Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>